St. Jude Medical completes its acquisition of CardioMEMS
St. Jude Medical plans to launch the CardioMEMS HF System in the U.S. Said system is the first and only FDA-approved heart failure monitoring device.
CardioMEMS
CardioMEMS develops wireless sensing and communication technology solutions for severe chronic cardiovascular diseases in the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms.